Antihypertensives, angiotensin, glucose and Alzheimer’s disease

References

• McKhann GM, Knopman DS, Chertkow H et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7(3), 263–269 (2011).
   PubMed Web of Science ®Google Scholar
• Sadowsky CH, Galvin JE. Guidelines for the management of cognitive and behavioral problems in dementia. J. Am. Board Fam. Med. 25(3), 350–366 (2012).
   PubMed Web of Science ®Google Scholar
• de la Torre JC. Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc. Psychiatry Neurol. 2012, 367516 (2012).
   PubMedGoogle Scholar
• Waldstein SR, Wendell CR, Lefkowitz DM et al. Interactive relations of blood pressure and age to subclinical cerebrovascular disease. J. Hypertens. 30(12), 2352–2356 (2012).
   PubMedGoogle Scholar
• Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 4(8), 487–499 (2005).
   PubMed Web of Science ®Google Scholar
• Beason-Held LL, Moghekar A, Zonderman AB, Kraut MA, Resnick SM. Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke 38(6), 1766–1773 (2007).
   PubMedGoogle Scholar
• Muller M, van der Graaf Y, Visseren FL, Mali WP, Geerlings MI; SMART Study Group. Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study. Ann. Neurol. 71(6), 825–833 (2012).
   PubMed Web of Science ®Google Scholar
• Schuff N, Matsumoto S, Kimiecik J et al. Cerebral blood flow in ischemic vascular dementia and Alzheimers disease by arterial spin labeling MRI. Alzheimers Dement. 5, 454–462 (2009).
   PubMed Web of Science ®Google Scholar
• Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis. Assoc. Disord. 13(Suppl. 3), S115–S123 (1999).
   PubMed Web of Science ®Google Scholar
• Weller RO, Boche D, Nicholl JA. Microvascular changes and CAA in AD and their potential impact on therapy. Acta Neuropathol. 118(1), 87–102 (2009).
   PubMed Web of Science ®Google Scholar
• Thal DR, Ghebremedhin E, Orantes M, Wiestler OD. Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J. Neuropathol. Exp. Neurol. 62(12), 1287–1301 (2003).
   PubMed Web of Science ®Google Scholar
• Breteler MM. Vascular involvement in cognitive decline and dementia: epidemiological evidence from the Rotterdam study and the Rotterdam scan study. Ann. NY Acad. Sci. 903, 457–465 (2000).
   PubMed Web of Science ®Google Scholar
• Debette S, Seshadri S, Beiser A et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77(5), 461–468 (2011).
   PubMed Web of Science ®Google Scholar
• Petrovitch H, White LR, Izmirilian G et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia Aging Study. Neurobiol. Aging 21(1), 57–62 (2000).
   PubMed Web of Science ®Google Scholar
• Sun X, He G, Qing H et al. Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl Acad. Sci. USA 103(49), 18727–18732 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhou K, Wang R et al. Hypoxia-inducible factor 1α (HIF-1α)-mediated hypoxia increases BACE1 expression and β-amyloid generation. J. Biol. Chem. 282(15), 10873–10880 (2007).
   PubMed Web of Science ®Google Scholar
• Gentile MT, Poulet R, Di Pardo A et al. β-amyloid deposition in brain is enhanced in mouse models of arterial hypertension. Neurobiol. Aging 30(2), 222–228 (2009).
   PubMed Web of Science ®Google Scholar
• Waldstein SR, Giggey PP, Thayer JF, Zonderman AB. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging. Hypertension 45(3), 374–379 (2005).
   PubMed Web of Science ®Google Scholar
• Stern Y. Cognitive reserve. Neuropsychologia 47(10), 2015–2028 (2009).
   PubMed Web of Science ®Google Scholar
• Spieth W. Cardiovascular health status, age, and psychological performance. J. Gerontol. 19, 277–284 (1964).
   PubMedGoogle Scholar
• Khachaturian AS, Zandi PP, Lyketsos CG et al. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch. Neurol. 63(5), 686–692 (2006).
   PubMed Web of Science ®Google Scholar
• Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM. Associations of anti-hypertensive treatments with Alzheimer’s disease, vascular dementia, and other dementias. J. Alzheimers Dis. 26(4), 699–708 (2011).
   PubMed Web of Science ®Google Scholar
• Igase M, Kohara K, Miki T. The association between hypertension and dementia in the Elderly. Int. J. Hypertens. 2012, 320648 (2012).
   PubMedGoogle Scholar
• Forette F, Seux ML, Staessen JA et al.; Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch. Intern. Med. 162(18), 2046–2052 (2002).
   PubMed Web of Science ®Google Scholar
• Itkin A, Dupres V, Dufrêne YF, Bechinger B, Ruysschaert JM, Raussens V. Calcium ions promote formation of amyloid β-peptide (1–40) oligomers causally implicated in neuronal toxicity of Alzheimer’s disease. PLoS ONE 6(3), e18250 (2011).
   Google Scholar
• Hoffman LB, Schmeidler J, Lesser GT et al. Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology 72(20), 1720–1726 (2009).
   PubMed Web of Science ®Google Scholar
• Tzourio C, Anderson C, Chapman N et al.; PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch. Intern. Med. 163(9), 1069–1075 (2003).
   PubMed Web of Science ®Google Scholar
• Fournier A, Oprisiu-Fournier R, Serot JM et al. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors. Expert Rev. Neurother. 9(9), 1413–1431 (2009).
   PubMed Web of Science ®Google Scholar
• Gard PR, Rusted JM. Angiotensin and Alzheimer’s disease: therapeutic prospects. Expert Rev. Neurother. 4(1), 87–96 (2004).
   PubMedGoogle Scholar
• Fyhrquist F, Saijonmaa O. Renin–angiotensin system revisited. J. Intern. Med. 264(3), 224–236 (2008).
   PubMed Web of Science ®Google Scholar
• Wright JW, Harding JW. Brain renin–angiotensin – a new look at an old system. Prog. Neurobiol. 95(1), 49–67 (2011).
   PubMed Web of Science ®Google Scholar
• Vanderheyden PM. From angiotensin IV binding site to AT4 receptor. Mol. Cell. Endocrinol. 302(2), 159–166 (2009).
   PubMed Web of Science ®Google Scholar
• Stragier B, De Bundel D, Sarre S et al. Involvement of insulin-regulated aminopeptidase in the effects of the renin–angiotensin fragment angiotensin IV: a review. Heart Fail. Rev. 13(3), 321–337 (2008).
   PubMed Web of Science ®Google Scholar
• Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, Type 2 diabetes, and cognitive function. J. Clin. Exp. Neuropsychol. 26(8), 1044–1080 (2004).
   PubMed Web of Science ®Google Scholar
• Ba-Tin L, Strike P, Tabet N. Diabetic peripheral microvascular complications: relationship to cognitive function. Cardiovasc. Psychiatry Neurol. 2011, 723434 (2011).
   PubMedGoogle Scholar
• Lindeman RD, Romero LJ, LaRue A et al.; New Mexico Elder Health Survey. A biethnic community survey of cognition in participants with Type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey. Diabetes Care 24(9), 1567–1572 (2001).
   PubMed Web of Science ®Google Scholar
• Gradman TJ, Laws A, Thompson LW, Reaven GM. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J. Am. Geriatr. Soc. 41(12), 1305–1312 (1993).
   PubMed Web of Science ®Google Scholar
• Hassing LB, Hofer SM, Nilsson SE et al. Comorbid Type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 33(4), 355–361 (2004).
   PubMed Web of Science ®Google Scholar
• Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer’s Disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol. Rev. doi:10.1212/WNL.0b013e3181f4d7f8 (2013) (Epub ahead of print).
   PubMedGoogle Scholar
• Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277(10), 813–817 (1997).
   PubMed Web of Science ®Google Scholar
• Dore GA, Elias MF, Robbins MA, Elias PK, Nagy Z. Presence of the APOE epsilon4 allele modifies the relationship between Type 2 diabetes and cognitive performance: the Maine–Syracuse Study. Diabetologia 52(12), 2551–2560 (2009).
   PubMedGoogle Scholar
• Farmer ME, White LR, Abbott RD et al. Blood pressure and cognitive performance. The Framingham Study. Am. J. Epidemiol. 126(6), 1103–1114 (1987).
   PubMed Web of Science ®Google Scholar
• Obisesan TO, Obisesan OA, Martins S et al. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey. J. Am. Geriatr. Soc. 56(3), 501–509 (2008).
   PubMed Web of Science ®Google Scholar
• Rastas S, Pirttilä T, Mattila K et al. Vascular risk factors and dementia in the general population aged >85 years: prospective population-based study. Neurobiol. Aging 31(1), 1–7 (2010).
   PubMedGoogle Scholar